DIABETIC (T2). FOOT ULCER. EXPOSED TENDON...Follow-up visit. The ulcer is healed. WEEK 1 Second 3C...
2
2020 I EVERY WOUND IS PERSONAL USA REAPPLIX INC / US 325 Miron Drive, Suite 140 Southlake · Texas 76092· USA [email protected] EUROPE (HQ) REAPPLIX A/S HQ / EUROPE Blokken 45 3460 Birkerød · Denmark [email protected] PATIENT • 64-year-old, Female • Type 2 diabetes, diagnosed age 24 • Non-smoker • Hypothyroid, current medication: ASA and synthroid WOUND HISTORY • Foot ulcer for 10 weeks, • The wound appeared as a consequence of ill-fitted shoes TREATMENT CHARACTERISTICS • Five 3C Patch® applications TREATMENT OUTCOME • The tendon was covered after the third application • The wound closed completely after the fifth 3C Patch® application • The wound remains closed at 2-weeks follow up after the last 3C Patch application DIABETIC (T2). FOOT ULCER. EXPOSED TENDON WWW.3CPATCH.COM WEEK 0 Before first 3C Patch ® treatment. WEEK 2 Third 3C Patch ® treatment. Wound shows new granulation tissue WEEK 5 Fourth 3C Patch ® treatment. The tendon is covered. WEEK 7 Fifth and final 3C Patch ® treatment. The wound is almost closed. WEEK 9 Follow-up visit. The ulcer is healed. WEEK 1 Second 3C Patch ® treatment. 3C Patch ® is in place. .
Transcript of DIABETIC (T2). FOOT ULCER. EXPOSED TENDON...Follow-up visit. The ulcer is healed. WEEK 1 Second 3C...
2020 I EVERY WOUND IS PERSONAL
USAREAPPLIX INC / US
325 Miron Drive, Suite 140 Southlake · Texas 76092· USA
EUROPE (HQ)REAPPLIX A/S HQ / EUROPE
Blokken 45 3460 Birkerød · Denmark
PATIENT• 64-year-old, Female• Type 2 diabetes, diagnosed age 24• Non-smoker• Hypothyroid, current medication: ASA and synthroid
WOUND HISTORY• Foot ulcer for 10 weeks, • The wound appeared as a consequence of ill-fitted shoes
TREATMENT CHARACTERISTICS• Five 3C Patch® applications
TREATMENT OUTCOME• The tendon was covered after the third application• The wound closed completely after the fifth 3C Patch® application • The wound remains closed at 2-weeks follow up after the last 3C Patch application
DIABETIC (T2). FOOT ULCER.EXPOSED TENDON
WWW.3CPATCH.COM
WEEK 0Before first 3C Patch® treatment.
WEEK 2Third 3C Patch® treatment. Wound shows new granulation tissue
WEEK 5Fourth 3C Patch® treatment. The tendon is covered.
WEEK 7Fifth and final 3C Patch® treatment.The wound is almost closed.
WEEK 9Follow-up visit. The ulcer is healed.
WEEK 1Second 3C Patch® treatment. 3C Patch® is in place..
Founded in 2008, Reapplix specializes in the biological treatment and management of hard-to-heal wounds, especially diabetic foot ulcers. Its innovative, patented 3C Patch® System draws on the individual patient’s capacity to heal and is clinically proven to accelerate wound healing of chronic diabetic foot ulcers and recommended by the IWGDF Guidelines 2019.1 Headquartered in Denmark, with sales and distribution teams in the US and Europe, Reapplix won the Danish 2018 EY Entrepreneur of the Year Award in the life science category.
OUR STORY
EUROPE (HQ)REAPPLIX A/S HQ / EUROPE
Blokken 45 · 3460 Birkerød [email protected]
VISIT US AT 3CPATCH.COM
USAREAPPLIX INC / US
325 Miron Drive, Suite 140 Southlake · Texas 76092· USA
3C Patch® is formerly known as LeucoPatch. 3C Patch is a trademark of Reapplix A/S, registered in the EU and the US. 3CP is a trademark of Reapplix A/S, registered in the EU and pending in the US. 02114 EU and US Ver.2.0
CONTACT
